BIOMAT Database Logo BIOMAT Database Logo

Synthesis of 9-Aminoacridine Derivatives as Anti-Alzheimer Agents. 2016

Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan pharmacistrabya@gmail.com.

In the present study, some 9-aminoacridine derivatives have been synthesized by condensation of 9-aminoacridine with substituted phenacyl, benzoyl, and benzyl halides (RM1-RM6). Compounds were investigated for acetylcholinesterase and butyrylcholinesterase inhibition potential, considering these enzymes playing a key role in Alzheimer's disease. All derivatives showed better inhibition of enzymes than the standard galantamine, whereas except RM4, all exhibit better results than tacrine, a well-known acridine derivative used for the treatment of Alzheimer's disease.

UI MeSH Term Description Entries
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000585 Aminacrine A highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator. 9-Aminoacridine,Acridinamine,Aminacrine Hydrochloride,Aminoacridine,Aminoacridine Hydrochloride,Aminopt,Mykocert,9 Aminoacridine,Hydrochloride, Aminacrine,Hydrochloride, Aminoacridine
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
Synthesis of 9-substituted derivatives of berberine as anti-HIV agents.
April 2011, European journal of medicinal chemistry,
Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
Design, Synthesis and Evaluation of Hesperetin Derivatives as Potential Multifunctional Anti-Alzheimer Agents.
June 2017, Molecules (Basel, Switzerland),
Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
Synthesis, Characterisation and Docking Studies of Thioxoquinoline Derivatives as Potential Anti-Alzheimer Agents.
January 2022, Current drug discovery technologies,
Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
9-Deoxopodophyllotoxin derivatives as anti-cancer agents.
August 1999, Bioorganic & medicinal chemistry letters,
Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
Panaxadiol carbamate derivatives: Synthesis and biological evaluation as potential multifunctional anti-Alzheimer agents.
November 2023, Bioorganic chemistry,
Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
June 2011, European journal of medicinal chemistry,
Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
Indoloquinoxaline derivatives as promising multi-functional anti-Alzheimer agents.
April 2022, Journal of biomolecular structure & dynamics,
Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents.
August 2019, ACS chemical neuroscience,
Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
Triptolide derivatives as potential multifunctional anti-Alzheimer agents: Synthesis and structure-activity relationship studies.
February 2018, Bioorganic & medicinal chemistry letters,
Rabya Munawar, and Nousheen Mushtaq, and Sadia Arif, and Ahsaan Ahmed, and Shamim Akhtar, and Sumaira Ansari, and Sadia Meer, and Zafar S Saify, and Muhammad Arif
Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents.
September 2016, Journal of medicinal chemistry,
Copied contents to your clipboard!